The incidence of diabetes has increased worldwide and its prevalence in CAD patients undergoing percutaneous coronary intervention (PCI) has been reported to be as high as 20–30%, with an increasing trend [ 14 , 15 ].
← all excerpts
Sirolimus-coated balloon in all-comer population of coronary artery disease patients: the EASTBOURNE DIABETES prospective registry.
1
—
—